SUMMARY Eighty five ovarian epithelial and non-epithelial tumours were studied by peroxidase histochemical staining for their reactivity with six monoclonal human milk fat globule (HMFG) antibodies, peanut agglutinin (PNA) lectin, and a monoclonal cytokeratin antibody. HMFG IIIC12 and cytokeratin antibodies distinguished epithelial from non-epithelial tumours. The staining patterns of mucinous and serous tumours were essentially different from each other; poorly differentiated anaplastic carcinomas showed similar antigenic content to that of the serous cystadenocarcinomas. Furthermore, staining with PNA lectin and HMFG antibodies was useful in distinguishing clear cell carcinomas from other malignant epithelial tumours of the ovary.
The treatment and prognosis for ovarian tumours depend on the spread, differentiation, and exact histological type.' Although Accepted for publication 25 June 1987 Material and methods
ANTIBODIES AND LECTINS
The production and characterisation ofmurine monoclonal cell lines secreting HMFG antibodies has been described previously.'4 5 Immunoglobulins were isolated from murine ascitic fluid by ammonium sulphate precipitation and purified with column cromatography (Sephacryl S-200, Pharmacia Fine Chemicals, Uppsala, Sweden). The biotinylated PNA lectin was purchased from Vector Laboratories and cytokeratin PKK-1 antibody from Labsystems (Helsinki, Finland).
SDS-PAGE AND IMMUNOBLOTTING
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting modifications from the methods described by Laemmli'6 and Towbin'7 were used. Briefly, samples were boiled in sample buffer, run in 10% SDS-PAGE, transferred electrically on to nitrocellulose paper, and stained with monoclonal HMFG antibodies as described previously. 8 The 
OTHER EPITHELIAL AND GRANULOSA CELL TUMOURS
Other epithelial tumours were all positive for cytokeratin antibody but negative for PNA lectin. As for HMFG-antibody reactivity, the antibody II1C12 positively stained all tumours, including the Brenner tumours, in which a cytoplasmic reaction was shown. The other HMFG antibodies generally failed to detect any antigenic material in these tumours. Clear cell carcinomas were an exception: a cytoplasmic staining reaction was shown in sections treated with other HMFG antibodies except HMFG IIIC12, which again showed only luminal membrane reactivity. Granulosa cell tumours gave negative staining results.
Discussion
We analysed 85 ovarian tumours for their reactivity with six monoclonal antibodies against HMFG and with PNA lectin. All epithelial tumours strongly stained with HMFG IIIC12 antibody; non-epithelial tumours showed no reactivity with the antibody. To date no monoclonal antibody has been shown to be specific for a certain type oftumour or even ovarian tissue,24 although some antibodies react preferentially either with mucinous25 or serous26 ovarian tumours. In our material serous, mucinous, endometrioid and clear cell carcinomas all showed a distinctive staining pattern when an immunohistochemical staining panel of six HMFG antibodies and peanut agglutinin lectin were used. The well defined staining pattern of the serous and anaplastic tumours suggests that the 10 anaplastic tumours previously identified as papillary ovarian carcinomas might, in fact, have been poorly differentiated serous cystadenocarcinomas of the ovary.
The reactivity of mucinous tumours with peanut agglutinin lectin was of interest as intracytoplasmic staining with PNA lectin was shown in borderline and malignant, but not in benign lesions. These results suggest that cytoplasmic PNA lectin positivity is a marker for ovarian epithelial cell differentiation. Similar PNA lectin binding characteristics have previously been observed in epithelial cells in breast cancer2728 as well as in intestinal neoplasms.-'
As for other epithelial tumours, clear cell carcinoma, a relatively rare ovarian tumour belonging to the "common epithelial tumours of the ovary" in the WHO classification,'9 has been the object of great controversy in the past. It is now considered to be a variant of the endometrioid tumour of the ovary.-"' Interestingly, in our material clear cell carcinomas could be distinguished from other epithelial neoplasms by their cytoplasmic staining reaction with monoclonal HMFG antibodies together with PNA lectin negativity. The observed antigenic differences between endometrioid and clear cell carcinomas might be due to the differing origins of these tumours. Our material is insufficient to draw definite conclusions on the histogenesis of these tumours.
Taken together, although immunohistochemical staining with one antibody can seldom be used to classify positively poorly differentiated ovarian tumours, an immunohistochemical staining panel including several HMFG and other antibodies32 and PNA lectin may be useful in the differential diagnosis of ovarian tumours.
